1. Home
  2. NAII vs RFL Comparison

NAII vs RFL Comparison

Compare NAII & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAII
  • RFL
  • Stock Information
  • Founded
  • NAII 1980
  • RFL N/A
  • Country
  • NAII United States
  • RFL United States
  • Employees
  • NAII N/A
  • RFL N/A
  • Industry
  • NAII Medicinal Chemicals and Botanical Products
  • RFL Real Estate
  • Sector
  • NAII Health Care
  • RFL Finance
  • Exchange
  • NAII Nasdaq
  • RFL Nasdaq
  • Market Cap
  • NAII 35.3M
  • RFL 36.1M
  • IPO Year
  • NAII 1987
  • RFL N/A
  • Fundamental
  • Price
  • NAII $5.80
  • RFL $1.44
  • Analyst Decision
  • NAII
  • RFL
  • Analyst Count
  • NAII 0
  • RFL 0
  • Target Price
  • NAII N/A
  • RFL N/A
  • AVG Volume (30 Days)
  • NAII 4.5K
  • RFL 20.4K
  • Earning Date
  • NAII 05-14-2024
  • RFL 06-14-2024
  • Dividend Yield
  • NAII N/A
  • RFL N/A
  • EPS Growth
  • NAII N/A
  • RFL N/A
  • EPS
  • NAII N/A
  • RFL N/A
  • Revenue
  • NAII $120,201,000.00
  • RFL $540,000.00
  • Revenue This Year
  • NAII N/A
  • RFL N/A
  • Revenue Next Year
  • NAII N/A
  • RFL N/A
  • P/E Ratio
  • NAII N/A
  • RFL N/A
  • Revenue Growth
  • NAII N/A
  • RFL 92.86
  • 52 Week Low
  • NAII $5.06
  • RFL $1.29
  • 52 Week High
  • NAII $7.62
  • RFL $2.52
  • Technical
  • Relative Strength Index (RSI)
  • NAII 42.28
  • RFL 46.62
  • Support Level
  • NAII $5.63
  • RFL $1.29
  • Resistance Level
  • NAII $5.88
  • RFL $1.54
  • Average True Range (ATR)
  • NAII 0.20
  • RFL 0.07
  • MACD
  • NAII -0.02
  • RFL 0.00
  • Stochastic Oscillator
  • NAII 39.42
  • RFL 57.69

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.

Share on Social Networks: